Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.98
+0.12003.11%
Post-market: 3.980.00000.00%19:54 EDT
Volume:20.57K
Turnover:81.83K
Market Cap:42.92M
PE:-2.06
High:4.05
Open:3.91
Low:3.85
Close:3.86
Loading ...
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 25, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]